MedPath

Effect of Acetaminophen on relief of bone pain due to PEG G-CSF

Phase 3
Conditions
Bone Pain Due to PEG G-CSF.
Non-follicular lymphoma
Registration Number
IRCT20190514043586N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

People with Solid Tumor or Lymphoma who receive PEG G-CSF due to neutropenia after chemotherapy

Exclusion Criteria

Bone matastasis
PFS more than 2
Osteomalacia proven with laboratory tests
CKD or ESRD
Active Rheumatologic disease
Uncontrolled Diabetes or Thyroid disease
Patients receiving chemotherapy drugs that have bone pain are a high prevalence of 10% (TAXAN family, bisphosphonate ...)
Pathologic fracture or fracture due to any reason
Naproxen use contraindication
Vitamin D level less than 20
Paget disease
Hyperparathyroidism
People who have had a score of over 6 in the bone pain score since the beginning of the project
Liver disease
History of Cardiac Arrhythmia
Patient who have not compliance for completing pain questionnaire

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain Score in Visual Analogue Scale(VAS) questionnaire. Timepoint: Day 0; One day after the end of first and third course of chemotherapy. Method of measurement: Visual Analogue Scale questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath